These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2298629)

  • 1. Supraglottic laryngeal carcinoma.
    Harwood AR
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):263-5. PubMed ID: 2298629
    [No Abstract]   [Full Text] [Related]  

  • 2. Deciding on optimal management of supraglottic carcinoma.
    Wang CC; Montgomery WW
    Oncology (Williston Park); 1991 Apr; 5(4):41-6; discussion 46, 49, 53. PubMed ID: 1831039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of treated T1N0 squamous carcinoma of the glottis.
    Kaiser TN; Sessions DG; Harvey JE
    Ann Otol Rhinol Laryngol; 1989 Mar; 98(3):217-9. PubMed ID: 2923397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glottic carcinomas: a retrospective study of 101 cases.
    Broniatowski M
    Ear Nose Throat J; 1985 Nov; 64(11):527-31. PubMed ID: 4064984
    [No Abstract]   [Full Text] [Related]  

  • 6. T3N0M0 glottic cancer: are more treatment modalities necessarily better?
    Laramore GE
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):423-5. PubMed ID: 7836098
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T3 and T4 carcinoma of the larynx--a retrospective study.
    Blokmanis A; Flores AD; Smith JM; Taylor MT
    J Otolaryngol; 1981 Jun; 10(3):195-8. PubMed ID: 7277559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective review in the management of T3 laryngeal squamous cell carcinoma: an expanding indication for transoral laser microsurgery.
    Butler A; Rigby MH; Scott J; Trites J; Hart R; Taylor SM
    J Otolaryngol Head Neck Surg; 2016 May; 45(1):34. PubMed ID: 27233357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glottic and supraglottic laryngeal cancer: epidemiology, treatment patterns and survival in 164 patients.
    Petrakos I; Kontzoglou K; Nikolopoulos TP; Papadopoulos O; Kostakis A
    J BUON; 2012; 17(4):700-5. PubMed ID: 23335528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends in T3 to T4 laryngeal cancer: a population-based long-term analysis.
    Reizenstein JA; Holmberg L; Bergqvist M; Linder A; Ekman S; Lödén B; Holmqvist M; Hellström K; von Beckerath M; Blomquist E; Bergström SN
    Head Neck; 2014 Dec; 36(12):1727-31. PubMed ID: 24166872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the laryngeal glottis therapy and end results.
    Skolnik EM; Yee KF; Wheatley MA; Martin LO
    Laryngoscope; 1975 Sep; 85(9):1453-66. PubMed ID: 1177637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
    Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early case of supraglottic carcinoma.
    Taskinen PJ
    Laryngoscope; 1975 Oct; 85(10):1643-9. PubMed ID: 1186394
    [No Abstract]   [Full Text] [Related]  

  • 16. Management and pitfalls of stage I/II glottic cancer.
    Tateya I; Hirano S; Kitamura M; Kada S; Ishikawa S; Kanda T; Asato R; Tanaka S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):62-7. PubMed ID: 20879821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laser-radiation therapy for T2N0M0 laryngeal-glottic cancer].
    Suzuki G; Hayabuchi N; Toda Y; Suefuji H; Ogo E; Nakajima T
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Mar; 62(4):151-5. PubMed ID: 12043218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supraglottic carcinoma.
    DeSanto LW
    Laryngoscope; 1992 Mar; 102(3):363-5. PubMed ID: 1545664
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommended organ preservation strategy for T2 unfavorable glottis cancer.
    Thankappan K
    J Clin Oncol; 2007 Feb; 25(6):735-6; author reply 736. PubMed ID: 17308284
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinicopathologic prognostic factors of laryngeal and pharyngeal tumors. III: Supraglottic carcinoma].
    Díaz Fernández C; Suárez Nieto C; Herrero Monge F; Llorente Pendas JL; Fernández Pello M; Núñez Batalla F
    Acta Otorrinolaringol Esp; 1993; 44(3):159-64. PubMed ID: 8357626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.